Trial reportActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2026
The effect of aryepiglottic fold release as an adjuvant step in surgery for Type I laryngomalacia.
Trial report in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to evaluate the efficacy of unilateral aryepiglottic fold release as an adjunctive surgical step in the management of Type I laryngomalacia. Methods: This study was prospectively conducted on a sample of paediatric patients with laryngomalacia. Our patients were randomly divided into Group A (study group, n = 25), undergoing adjuvant aryepiglottic fold release (AEFR), and Group B (control group, n = 25), who did not undergo adjuvant AEFR. Demographic data, clinical features, and outcome measures were compared between groups. Results: A highly significant difference was observed in the time to resolution of postoperative stridor, with the study group demonstrating markedly earlier symptom resolution compared to the control group. Furthermore, the percentage change in oxygen saturation in both states was also significantly greater in the study group, reflecting a highly significant intergroup difference. Additionally, the incidence of perioperative respiratory adverse events (PRAEs) was significantly lower in the study group than in the control group. Conclusions: Unilateral AEFR, as an adjunctive procedure, marks a significant advancement in management of Type I laryngomalacia. It offers targeted improvement in oxygen saturation levels during both wakefulness and sleep. Furthermore, the technique has been shown to decrease the incidence of PRAEs, delivering significant clinical and operational benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.